Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Eyepoint Pharmaceuticals Inc (NQ: EYPT )

8.550 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 28, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 8.550
Bid (Size) 8.250 (1)
Ask (Size) 9.800 (17)
Prev. Close 8.550
Today's Range 8.550 - 8.550
52wk Range 3.511 - 15.06
Shares Outstanding 28,741,475
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
EyePoint Pharmaceuticals to Report Second Quarter 2021 Financial Results on August 4, 2021
From GlobeNewswire News Releases
EyePoint Pharmaceuticals Receives Preliminary Extension to Pass-Through Payment Status for DEXYCU®
From GlobeNewswire News Releases

Performance

YTD
-5.11%
-5.11%
1 Month
-3.50%
-3.50%
3 Month
-20.61%
-20.61%
6 Month
-12.84%
-12.84%
1 Year
+15.54%
+15.54%

More News

Read More
EyePoint Pharmaceuticals Reports Positive 30-day Safety Results for all Cohorts from the DAVIO Trial of EYP-1901 for wet-AMD
From GlobeNewswire News Releases
EyePoint Pharmaceuticals Announces New Category III CPT Code for DEXYCU® Intraocular Suspension, Approved by the American Medical Association
From GlobeNewswire News Releases
EyePoint Pharmaceuticals Joins Russell 2000® and Russell 3000® Index
From GlobeNewswire News Releases
EyePoint Pharmaceuticals to Participate in Fireside Chat at the Jefferies Virtual Healthcare Conference
From GlobeNewswire News Releases
EyePoint Pharmaceuticals Announces Completion of Enrollment of Phase 1 DAVIO Clinical Trial of EYP-1901 for the Potential Treatment of Wet AMD
From GlobeNewswire News Releases
EyePoint Pharmaceuticals Reports First Quarter 2021 Financial Results and Highlights Recent Corporate Developments
From GlobeNewswire News Releases
EyePoint Pharmaceuticals to Report First Quarter 2021 Financial Results and Discuss Recent Corporate Developments on May 5, 2021
From GlobeNewswire News Releases
EyePoint Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Corporate Developments
From GlobeNewswire News Releases
RSI Alert: EyePoint Pharmaceuticals (EYPT) Now Oversold
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.